表紙
市場調查報告書

生物可吸收支架 - 醫療設備的開發平台評估:2020年

Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2020

出版商 GlobalData 商品編碼 959838
出版日期 內容資訊 英文
訂單完成後即時交付
價格
生物可吸收支架 - 醫療設備的開發平台評估:2020年 Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2020
出版日期: 2020年09月01日內容資訊: 英文
簡介

生物可吸收支架,也稱為生物再吸收性或生物分解性的冠狀動脈支架。

本報告提供生物可吸收支架的開發中產品調查分析,各開發階段比較分析為焦點,開發產品的主要企業,進行中的臨床試驗相關資訊等系統性資訊。

目錄

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 生物可吸收支架 - 開發中產品:各開發階段
  • 生物可吸收支架 - 開發中產品:各地區
  • 生物可吸收支架 - 開發中產品:各法規途徑
  • 生物可吸收支架 - 開發中產品:各核准預定日
  • 生物可吸收支架 - 進行中的臨床試驗

第4章 生物可吸收支架 - 開發中的開發中產品:各企業

  • 生物可吸收支架企業 - 開發中產品:各開發階段
  • 生物可吸收支架 - 開發中產品:各開發階段

第5章 生物可吸收支架企業與產品概要

  • Abbott Vascular Inc
  • Amaranth Medical Inc
  • Arterius Ltd
  • Biosensors International Group Ltd
  • Biosten, LLC
  • Biotronik AG
  • Biotronik SE & Co KG
  • Boston Scientific Corp
  • Cardionovum GmbH
  • Cordis Corp
  • HangZhou HuaAn Biotechnology Co., Ltd.
  • Icon Interventional Systems, Inc.
  • Japan Stent Technology Co., Ltd.
  • Kyoto Medical Planning Co Ltd
  • Lifetech Scientific (Shenzhen) Co Ltd
  • Manli Cardiology Ltd
  • Micell Technologies Inc
  • Michigan Technological University
  • MicroPort Scientific Corp
  • Minvasys SAS
  • MIV Therapeutics Inc
  • NanoCoeur, Inc.
  • North Carolina State University
  • Northwestern University
  • OrbusNeich
  • Pediastent LLC
  • QualiMed Innovative Medizinprodukte GmbH
  • REVA Medical Inc
  • S3V Vascular Technologies
  • Tepha Inc
  • University of Alabama at Birmingham
  • University of Florida
  • University of Strathclyde
  • VasoTech Inc.
  • Xenogenics Corporation

第6章 生物可吸收支架 - 最近的開發

第7章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0985EPD

GlobalData's Medical Devices sector report, "Bioabsorbable Stents (BAS) - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Bioabsorbable Stents (BAS) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Bioabsorbable stents are also known as bioreabsorbable or biodegradable coronary stents. They are made from the material found in dissolvable sutures known as polylactic acid.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bioabsorbable Stents (BAS) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bioabsorbable Stents (BAS) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Bioabsorbable Stents (BAS) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Bioabsorbable Stents (BAS) Overview

3 Products under Development

  • 3.1 Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
  • 3.2 Bioabsorbable Stents (BAS) - Pipeline Products by Territory
  • 3.3 Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path
  • 3.4 Bioabsorbable Stents (BAS) - Pipeline Products by Estimated Approval Date
  • 3.5 Bioabsorbable Stents (BAS) - Ongoing Clinical Trials

4 Bioabsorbable Stents (BAS) - Pipeline Products under Development by Companies

  • 4.1 Bioabsorbable Stents (BAS) Companies - Pipeline Products by Stage of Development
  • 4.2 Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development

5 Bioabsorbable Stents (BAS) Companies and Product Overview

  • 5.1 Abbott Vascular Inc Company Overview
  • 5.2 Amaranth Medical Inc Company Overview
  • 5.3 Arterius Ltd Company Overview
  • 5.4 Biosensors International Group Ltd Company Overview
  • 5.5 Biosten, LLC Company Overview
  • 5.6 Biotronik AG Company Overview
  • 5.7 Biotronik SE & Co KG Company Overview
  • 5.8 Boston Scientific Corp Company Overview
  • 5.9 Cardionovum GmbH Company Overview
  • 5.10 Cordis Corp Company Overview
  • 5.11 HangZhou HuaAn Biotechnology Co., Ltd. Company Overview
  • 5.12 Icon Interventional Systems, Inc. Company Overview
  • 5.13 Japan Stent Technology Co., Ltd. Company Overview
  • 5.14 Kyoto Medical Planning Co Ltd Company Overview
  • 5.15 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
  • 5.16 Manli Cardiology Ltd Company Overview
  • 5.17 Micell Technologies Inc Company Overview
  • 5.18 Michigan Technological University Company Overview
  • 5.19 MicroPort Scientific Corp Company Overview
  • 5.20 Minvasys SAS Company Overview
  • 5.21 MIV Therapeutics Inc Company Overview
  • 5.22 NanoCoeur, Inc. Company Overview
  • 5.23 North Carolina State University Company Overview
  • 5.24 Northwestern University Company Overview
  • 5.25 OrbusNeich Company Overview
  • 5.26 Pediastent LLC Company Overview
  • 5.27 QualiMed Innovative Medizinprodukte GmbH Company Overview
  • 5.28 REVA Medical Inc Company Overview
  • 5.29 S3V Vascular Technologies Company Overview
  • 5.30 Tepha Inc Company Overview
  • 5.31 University of Alabama at Birmingham Company Overview
  • 5.32 University of Florida Company Overview
  • 5.33 University of Strathclyde Company Overview
  • 5.34 VasoTech Inc. Company Overview
  • 5.35 Xenogenics Corporation Company Overview

6 Bioabsorbable Stents (BAS)- Recent Developments

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Table 1: Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
  • Table 2: Bioabsorbable Stents (BAS) - Pipeline Products by Territory
  • Table 3: Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path
  • Table 4: Bioabso

List of Figures

List of Figures

  • Figure 1: Bioabsorbable Stents (BAS) - Pipeline Products by Stage of Development
  • Figure 2: Bioabsorbable Stents (BAS) - Pipeline Products by Territory
  • Figure 3: Bioabsorbable Stents (BAS) - Pipeline Products by Regulatory Path
  • Figure 4: Bi